U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT06884085) titled 'A Study to Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B' on March 13.

Brief Summary: Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-227 in healthy subjects.

Study Start Date: Feb. 18

Study Type: INTERVENTIONAL

Condition: Primary Hypertension

Intervention: DRUG: Co-administration of AD-227A and AD-227B

Co-administration of AD-227A 1Tab. and AD-227B 1Tab., Per Oral

DRUG: Administration of AD-227A

Administration of AD-227A 1Tab., Per Oral

Recruitment Status: RECRUITING

Sponsor: Addpharma Inc.

Published by HT Digital Co...